| 英文别名: |
2alpha,3beta,19alpha-trihydroxyurs-12-ene-23-carboxyl-28-O-beta-D-glucopyranosyl ester;sauvissimoside R1;suavissimoside F1;suavissimoside R 1;suavissmoside R1;suvavissimoside R1;Suavissimoside R1;(2R,3R,4S,4Ar,6aR,6bS,8aS,11R,12R,12aS,14aR,14bR)-2,3,12-trihydroxy-4,6a,6b,11,12,14b-hexamethyl-8a-;(+)-Suavissimoside F 1;Suavissimoside F 1;MEGxp0_000350;NCGC00169718-03_C36H56O12_beta-D-Glucopyranose, 1-O-[(2alpha,3beta,5xi,9xi)-2,3,19,24-tetrahydroxy-24,28-dioxours-12-en-28-yl]-;NCGC00169718-03;FT-0775930;Compound NP-000893;95645-51-5;AKOS040740111;NCGC00169718-01;ACon1_001057;CS-0101593;FS-7226;SCHEMBL868799;(2R,3R,4S,4aR,6aR,6bS,8aS,11R,12R,12aS,14aR,14bR)-2,3,12-trihydroxy-4,6a,6b,11,12,14b-hexamethyl-8a-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycarbonyl-1,2,3,4a,5,6,7,8,9,10,11,12a,14,14a-tetradecahydropicene-4-carboxylic acid;HY-N7025;AKOS040760725;(2R,3R,4S,4aR,6aR,6bS,8aS,11R,12R,12aS,14aR,14bR)-2,3,12-trihydroxy-4,6a,6b,11,12,14b-hexamethyl-8a-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxycarbonyl-1,2,3,4a,5,6,7,8,9,10,11,12a,14,14a-tetradecahydropicene-4-carboxylic acid;DA-67821 |